The influence of combined glycolytic inhibitor, respiratory inhibitor, and protein antagonist on experimental tumor growth.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D005459:Fluorides / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use*; D051379:Mice; D010629:Phenformin / Q000627:therapeutic use*; D012511:Sarcoma 37 / Q000188:drug therapy*
D010629:Phenformin; D008558:Melphalan; D005459:Fluorides